See also this year's filing and all EDGAR filings for this company.
PDF Report 0000906709_2023_Nektar_Therapeutics.pdf
Logs
Graph
Absolute values for 0000906709, Nektar Therapeutics
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 545,968,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 76,501,000 |
| 2 | PropertyPlantAndEquipmentNet | 32,451,000 |
| 3 | remainder_Assets | 55,680,000 |
| 4 | LiabilitiesCurrent | 68,204,000 |
| 5 | LiabilitiesNoncurrent | 120,380,000 |
| 6 | remainder_Liabilities | 155,378,000 |
| 7 | CostOfGoodsAndServicesSold | 22,062,982 |
| 8 | SellingGeneralAndAdministrativeExpense | 90,895,774 |
| 9 | ResearchAndDevelopmentExpense | 114,268,910 |
| 10 | remainder_Expenses | 874,970 |
| 11 | remainder_Revenues | 95,118,681 |
| 12 | remainder_NetIncome | -26,997,809 |
| 13 | remainder_ComprehensiveNetIncome | -2,349,735 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 710,600,000 |
| 1 | Liabilities | 343,962,000 |
| 2 | Expenses | 228,102,636 |
| 3 | Revenues | 95,118,681 |
| 4 | StockholdersEquity | 366,638,000 |
| 5 | NetIncome | -159,981,764 |
| 6 | ComprehensiveNetIncome | -161,156,632 |
| 7 | BaseVar | 703,565,430 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.21 |
| 9 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
